A Review of Causal Inference for External Comparator Arm Studies Gerd RippinNicolás BallariniFrancesco Pignatti Review Article 27 July 2022 Pages: 815 - 837
Kidney Damage and Stress Biomarkers for Early Identification of Drug-Induced Kidney Injury: A Systematic Review Ravi J. DesaiChristina L. KazarovSandra L. Kane-Gill Systematic Review 13 July 2022 Pages: 839 - 852
Combining Machine Learning with a Rule-Based Algorithm to Detect and Identify Related Entities of Documented Adverse Drug Reactions on Hospital Discharge Summaries Hui Xing TanChun Hwee Desmond TeoSreemanee Raaj Dorajoo Original Research Article 06 July 2022 Pages: 853 - 862
A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS) Lorenzo Villa-ZapataAinhoa Gómez-LumbrerasDaniel C. Malone Original Research Article 14 July 2022 Pages: 863 - 871
Short-Term Risk of Unintentional Poisoning After New Initiation of Central Nervous System Medications in Swedish Older Adults: A Register-Based Case-Crossover Study Yang ZhaoYajun LiangJette Möller Original Research Article Open access 05 July 2022 Pages: 873 - 880
Developing Strategic Recommendations for Implementing Smart Pumps in Advanced Healthcare Systems to Improve Intravenous Medication Safety Adam SutherlandMatthew D. JonesBryony Dean Franklin Leading Article 15 July 2022 Pages: 881 - 889
Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database Michele FusaroliValentina IsgròGianluca Trifirò Original Research Article Open access 12 July 2022 Pages: 891 - 908
Safety of Praziquantel and Albendazole Coadministration for the Control and Elimination of Schistosomiasis and Soil-Transmitted Helminths Among Children in Rwanda: An Active Surveillance Study Joseph KabatendeAbbie BarryEleni Aklillu Original Research Article Open access 11 July 2022 Pages: 909 - 922
Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands” Rujittika MungmunpuntipantipViroj Wiwanitkit Letter to the Editor 15 July 2022 Pages: 923 - 923
Authors’ Reply to Mungmunpuntipantip et al.’s Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands” Agnes KantFlorence van Hunsel Letter to the Editor 15 July 2022 Pages: 925 - 926
Correction to: Machine Learning in Causal Inference: Application in Pharmacovigilance Yiqing ZhaoYue YuYuan Luo Correction Open access 23 June 2022 Pages: 927 - 927